In its
submission to the House of Commons’ Standing Committee on Health in September 2017, the CMA reinforced the need for a public health approach in the legalization of cannabis for recreational purpose.

Cannabis for medical purposes

Government regulation currently permits the use of cannabis for medical purposes. While the CMA recognizes that some individuals suffering from terminal illness or chronic disease may obtain relief with cannabis, there is insufficient evidence on risks and benefits, the proper dosage and potential interactions with other medications.

With the legalization of cannabis now underway, we believe that a separate regulatory framework for medical use is no longer necessary, and look forward to working with the federal government to eliminate this framework as soon as possible.

Learn more about cannabis and the CMA

For more information on the CMA’s work on cannabis, please contact
yourvoice@cma.ca.